ArticleBiomedicines2022

Prediction of Conserved HLA Class I and Class II Epitopes from SARS-CoV-2 Licensed Vaccines Supports T-Cell Cross-Protection against SARS-CoV-1.

Daniel LópezPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.